- Home
- ENX vs RCEL Comparison
ENX vs RCEL Comparison
Compare ENX & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- RCEL
- Stock Information
- Founded
- ENX 2002
- RCEL N/A
- Country
- ENX United States
- RCEL United States
- Employees
- ENX N/A
- RCEL N/A
- Industry
- ENX Finance/Investors Services
- RCEL Medical/Dental Instruments
- Sector
- ENX Finance
- RCEL Health Care
- Exchange
- ENX Nasdaq
- RCEL Nasdaq
- Market Cap
- ENX 169.0M
- RCEL 152.1M
- IPO Year
- ENX N/A
- RCEL N/A
- Fundamental
- Price
- ENX $9.39
- RCEL $4.88
- Analyst Decision
- ENX
- RCEL Strong Buy
- Analyst Count
- ENX 0
- RCEL 4
- Target Price
- ENX N/A
- RCEL $14.75
- AVG Volume (30 Days)
- ENX 25.4K
- RCEL 456.8K
- Earning Date
- ENX 01-01-0001
- RCEL 08-07-2025
- Dividend Yield
- ENX 3.94%
- RCEL N/A
- EPS Growth
- ENX N/A
- RCEL N/A
- EPS
- ENX 0.16
- RCEL N/A
- Revenue
- ENX N/A
- RCEL $74,884,000.00
- Revenue This Year
- ENX N/A
- RCEL $57.16
- Revenue Next Year
- ENX N/A
- RCEL $36.69
- P/E Ratio
- ENX $61.00
- RCEL N/A
- Revenue Growth
- ENX N/A
- RCEL 38.32
- 52 Week Low
- ENX $7.84
- RCEL $3.60
- 52 Week High
- ENX $10.07
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- ENX 57.20
- RCEL 43.57
- Support Level
- ENX $9.28
- RCEL $4.58
- Resistance Level
- ENX $9.48
- RCEL $6.00
- Average True Range (ATR)
- ENX 0.11
- RCEL 0.40
- MACD
- ENX 0.00
- RCEL -0.05
- Stochastic Oscillator
- ENX 22.77
- RCEL 53.33
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.